Immunology

📚 01 General Pediatrics • 🎯 36 High-Yield MCQs • Nelson 22nd Edition Standard

Immune System Overview & Classification

  • Adaptive Immune System Components: ((IMM001)): Composed of T lymphocytes (cell-mediated immunity, MHC recognition, cytokine production) and B lymphocytes (humoral immunity, antigen-specific antibody production via plasma cells). Hallmark features are antigen specificity, immunologic memory, and clonal expansion/contraction.

Primary Antibody & B-Cell Deficiencies

  • X-Linked Agammaglobulinemia (XLA / Bruton Agammaglobulinemia): ((((IMM021)) · ((IMM023)))): Caused by mutations in the **BTK gene, resulting in maturation arrest at the pre-B-cell stage. Presents after 6 months of age** (when maternal IgG wanes) with recurrent pyogenic infections (pneumonia, otitis, meningitis) and atrophied tonsils and lymph nodes. Flow cytometry shows absent CD19+ B cells with normal T-cell numbers and severely decreased serum immunoglobulins (IgG, IgA, IgM).
  • Common Variable Immunodeficiency & Selective IgA Deficiency: ((((IMM007)) · ((IMM009)) · ((IMM025)))): Selective IgA deficiency is the most common primary immunodeficiency, defined by serum IgA <5–10 mg/dL with normal IgG/IgM and normal T cells, diagnosed only after 4 years of age. Features include sinopulmonary infections, Giardia lamblia diarrhea, celiac association, and risk of anaphylaxis from plasma-containing blood products (due to anti-IgA antibodies).
  • X-Linked Hyper-IgM Syndrome: ((((IMM024)) · ((IMM026)))): Caused by mutations in the **CD40LG gene** (CD40L/CD154 deficiency on activated CD4+ T cells), leading to a defect in class switch recombination and somatic hypermutation. Characterized by markedly elevated IgM with low/absent IgG, IgA, and IgE, and susceptibility to pyogenic and opportunistic infections.

Cellular, Combined & Phagocytic Deficiencies

  • DiGeorge Syndrome (22q11.2 Deletion): ((((IMM003)) · ((IMM005)) · ((IMM008)))): Caused by microdeletion of chromosome 22q11.2 disrupting the third and fourth pharyngeal pouches. Classic triad/findings include conotruncal cardiac anomalies (Tetralogy of Fallot, truncus arteriosus), hypocalcemia/neonatal seizures (parathyroid hypoplasia), and thymic hypoplasia leading to T-cell deficiency. Note: Cleft palate is seen, but cleft lip is not a feature.
  • Wiskott-Aldrich Syndrome (WAS): ((((IMM002)) · ((IMM022)))): Caused by mutations in the **WAS gene** (defective actin cytoskeleton). Characterized by the WATER mnemonic: Wiskott-Aldrich, Atopic dermatitis (eczema), Thrombocytopenia with small platelets (low MPV), Elevated IgE/IgA, and Recurrent infections. Major non-infectious, non-bleeding cause of death is EBV-associated B-cell malignancies.
  • Leukocyte Adhesion Deficiency (LAD-1 & LAD-3): ((((IMM011)) · ((IMM012)) · ((IMM013)) · ((IMM027)) · ((IMM028)))): Autosomal recessive disorders of neutrophil migration. LAD-1 (ITGB2/CD18 defect) presents with delayed umbilical cord separation (>3 weeks), marked leukocytosis (WBC >50,000/mm³), and recurrent bacterial infections without pus formation. LAD-3 (FERMT3/Kindlin-3 defect) uniquely combines leukocyte adhesion failure with defective platelet aggregation and bleeding tendencies (resembling Glanzmann thrombasthenia).
  • Chediak-Higashi Syndrome: ((((IMM014)) · ((IMM015)) · ((IMM029)))): Autosomal recessive mutations in the **LYST gene** (chromosome 1q2-q44) causing abnormal lysosomal trafficking and giant granules. Features include partial oculocutaneous albinism (silvery hair, light skin), neutrophil dysfunction (recurrent staphylococcal infections), prolonged bleeding time with normal platelets, progressive peripheral neuropathy, and risk of a fatal HLH-like accelerated phase. Management mainstay is early allogeneic HSCT (which corrects hematologic/immune defects but may not halt neurodegeneration).
  • Myeloperoxidase (MPO) Deficiency: ((IMM016)): Relatively common defect in neutrophil oxidative killing. Most individuals are asymptomatic due to compensatory mechanisms and MPO deficiency is typically detected incidentally on neutrophil function testing (e.g., NBT/DHR).
  • Chronic Granulomatous Disease (CGD) & Vaccine Safety: ((IMM030)): Defect in NADPH oxidase causing impaired intracellular killing of catalase-positive organisms (S. aureus, Serratia, Aspergillus). Adaptive immunity is intact, allowing most viral vaccines, but live BCG vaccine is absolutely contraindicated.

Complement Deficiencies

  • Terminal Complement vs. Early Classical Pathways: ((((IMM034)) · ((IMM035)))): Recurrent Neisseria meningitidis infections with normal immunoglobulins/neutrophils indicate a terminal complement pathway defect (C5-C9), evaluated by CH50 assay. Conversely, early classical pathway deficiencies (C1q, C2, C4)—especially C1q—strongly predispose to an SLE-like autoimmune syndrome (malar rash, photosensitivity, positive ANA) due to impaired immune complex clearance.

Hematopoietic Stem Cell Transplantation (HSCT) Complications

  • Infectious Phases Post-HSCT: ((IMM019)): Early (<30 days): Dominated by neutropenia-associated bacterial and Candida infections. Intermediate (30–100 days): CMV, opportunistic viruses, and invasive molds (e.g., Aspergillus). Late (>100 days): Chronic GVHD and encapsulated organisms.
  • Veno-Occlusive Disease (VOD) / Sinusoidal Obstructive Syndrome: ((IMM017)): Early complication (≤30 days post-transplant) featuring tender hepatomegaly, right upper quadrant pain, rapid weight gain/ascites, and hyperbilirubinemia. Severity is graded via bilirubin, weight gain, renal, and respiratory status.
  • Graft Failure & PTLD: ((((IMM018)) · ((IMM020)))): Primary graft failure is defined as failure to achieve an ANC ≥0.5 × 10⁹/L by day +28 with donor engraftment failure. EBV-associated PTLD presents early (1–6 months) after T-cell depleted transplants; first-line therapy includes reduction of immunosuppression and rituximab.
  • Transplant-Related Pulmonary & Inflammatory Complications: ((((IMM031)) · ((IMM033)))): Bronchiolitis obliterans is a pulmonary manifestation of chronic GVHD (associated with sicca/scleroderma), managed with systemic immunosuppression and inhaled therapies. Immune Reconstitution Inflammatory Syndrome (IRIS) causes paradoxical worsening of inflammatory symptoms (e.g., lymphadenopathy) during immune recovery despite effective antimicrobial therapy.

Complement and Angioedema Disorders

  • Hereditary Angioedema Type I: ((IMM036)): Autosomal dominant disorder caused by quantitative deficiency of C1 esterase inhibitor (C1-INH), accounting for ~85% of HAE cases; characterized by recurrent, non-pruritic angioedema of the face, extremities, larynx, or GI tract triggered by minor trauma. Diagnostic hallmarks include low serum C4 and decreased C1-INH antigenic level and function due to uncontrolled bradykinin production. - Distinguishing features: Allergic angioedema always presents with urticaria, itching, and responds to epinephrine/antihistamines; HAE is completely unresponsive to epinephrine, antihistamines, or corticosteroids. ACE-inhibitor–induced angioedema also involves bradykinin buildup but lacks a familial history and complement abnormalities.